#GoldenCross $MNOV at 12.82 R14 HiLo 97% T1Y 20 strong_buy fwdPE -16.6 DIV N/A #MediciNova #stocks #trading #finance #market

2019-05-15
180 Views

Golden Cross detected for MNOV (MediciNova, Inc.) at the close price of 12.82. Trading at a 97 % level between the 52week High (13.00) and 52week Low (6.68). The average analyst 1-year target price is 20.0 with an average strong_buy and a score of 0.0.

Golden Cross
14 %
MNOV
12.82
MediciNova, Inc.
HiLo
97.2 %
Support
11.06
Resistance
12.82
50DMA
9.87
200DMA
9.86
52week high
13.00
52week low
6.68
10DMA
12.03
20DMA
11.29
100 Mean
9.30
Volume
141079
AvgDayVol
93557
MarketCap
552044544
EBITDA
-15874278
Revenue
0
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index 100 Current 57.5 MA20 -729.17 Lower 405.91 Upper Bound #stocks #trading #markets #finance
Global Indicators,
9 views
Global Indicators,
9 views

HILO Index 100 Current 57.5 MA20 -729.17 Lower 405.91 Upper Bound #stocks #trading #markets #finance

Andreas Aigner - 2020-06-02

HILO Index 100 Current 57.5 MA20 -729.17 Lower 405.91 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index -7.13 Avg 63.66 Std -2 Curr #stocks #trading #markets #finance
Global Indicators,
10 views
Global Indicators,
10 views

Demark B/S Index -7.13 Avg 63.66 Std -2 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-06-02

Demark B/S Index -7.13 Avg 63.66 Std -2 Curr #stocks #trading #markets #finance

50/200 DMA Index -17.15 Avg 31.95 Std 5 Curr #stocks #trading #markets #finance
Global Indicators,
8 views
Global Indicators,
8 views

50/200 DMA Index -17.15 Avg 31.95 Std 5 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-06-02

50/200 DMA Index -17.15 Avg 31.95 Std 5 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.